Mounjaro Dose Guide: From 2.5mg to 15mg and What Happens at Each Step

All medical information is reviewed by our clinical partners at MedicOnline.

Dr. Jahan Khan, CMO @ MedicOnline

IMC 409788

Two of the most common questions from people already on Mounjaro is their specific dose are about "mounjaro 7.5mg side effects" or "moving from 5mg to 10mg mounjaro." That makes sense, because each dose increase feels like a mini restart, and knowing what other people experience at the same stage helps you gauge whether what you are feeling is normal.

This guide covers every dose level available in Ireland, explains how your doctor decides when and whether to increase, and gives you practical strategies for managing the transition between doses. If you are not yet on treatment and want to understand the eligibility criteria first, see our guide to Mounjaro eligibility in Ireland.

How the Dose Escalation Works

Mounjaro uses a stepped titration, starting low and increasing gradually. The purpose is to give your body time to adjust to each dose before moving to the next one, which reduces the severity of side effects - particularly the gastrointestinal ones like nausea and constipation that are most common in the early weeks.

Your doctor decides when to increase based on how you are tolerating the current dose and whether you are seeing clinical progress. There is no fixed rule that says you must move up every four weeks. Some patients stay at a lower dose for longer if it is working well or if side effects need more time to settle, and that is perfectly fine.

It is also worth knowing that not everyone ends up on the maximum dose. Many patients find their best balance of results and tolerability at 7.5mg or 10mg, and their doctor keeps them there. The goal is the dose that works for you, not the highest number on the scale.

A prescription for Mounjaro is only issued after a full clinical assessment by an IMC-registered doctor, and ongoing dose decisions are part of the medical oversight that should accompany this treatment.

Not everyone climbs every step. Your doctor may pause, extend, or stop escalating when the current dose is working well.

2.5mg: The Starting Dose (Weeks 1-4)

This is where everyone begins, and it is deliberately gentle. The 2.5mg dose is sub-therapeutic for weight loss, meaning it is not expected to produce significant results on its own. Its job is to introduce tirzepatide to your system and let your gut adapt to the change in how food moves through it.

Most patients notice very little at this dose. Some feel a mild reduction in appetite or a subtle sense of fullness after smaller meals, but many feel no different at all during the first week or two. If that is your experience, it does not mean the medication is not working - it means the starting dose is doing what it is supposed to do, which is easing you in.

Side effects at 2.5mg are typically mild if present at all. Occasional nausea in the first day or two after your injection is the most common report, and it usually passes quickly. Some patients notice mild changes in bowel habits.

What to focus on at this stage: Building the habits that will matter more as your appetite drops - prioritising protein at every meal, staying well hydrated, and establishing your injection day routine.

5mg: The First Real Step (Weeks 5-8)

The increase from 2.5mg to 5mg is where most patients first feel the medication's effects properly. Appetite suppression becomes more noticeable, portion sizes start shrinking naturally, and the background hum of food-related thoughts begins to quiet down.

This is also the dose increase where side effects are most commonly reported. Nausea is the most frequent one, typically appearing in the first two to three days after the higher dose and settling within a week. Some patients experience constipation, mild bloating, or changes in energy levels as their calorie intake naturally decreases.

The side effects at 5mg tend to follow the same pattern they did at 2.5mg, just a bit more noticeable. If you managed the starting dose without much trouble, you will likely manage this one too, especially if you apply the same strategies around eating smaller meals, avoiding heavy or greasy food on injection days, and drinking plenty of water.

What to focus on at this stage: Many patients start to see early weight loss in this phase, though the rate varies considerably between individuals and is not something to compare with anyone else. Keep your protein intake up even as your appetite falls - this is when the risk of eating too little starts to become real.

7.5mg: The Middle Ground (Weeks 9-12)

By the time you reach 7.5mg, your body has had two months to adapt to tirzepatide, and most patients find this dose increase easier than the jump to 5mg. Side effects, if they return at all, tend to be milder and shorter-lived because your system already knows what to expect.

Appetite suppression at 7.5mg is typically quite pronounced. Many patients describe feeling genuinely satisfied after meals in a way they have not experienced before, and the effort required to make healthy food choices decreases noticeably because the cravings and food noise have quietened further.

This is a dose where some patients find their sweet spot. If you are losing weight steadily, tolerating the medication well, and feeling good, your doctor may recommend staying at 7.5mg rather than continuing to increase. There is no clinical requirement to keep escalating if the current dose is delivering results.

What to focus on at this stage: If you have not already connected with a dietitian, now is a good time. Your eating patterns have changed significantly from where they were three months ago, and getting personalised guidance on how to eat well within a reduced appetite helps ensure you are getting enough of the right nutrients.

10mg: Stepping Up (Weeks 13-16)

The 10mg dose represents a meaningful increase in the medication's effect, and patients who move to this level often see an acceleration in their weight loss trajectory compared to the earlier doses. The dual GIP/GLP-1 mechanism is working at a higher intensity, and for many patients this is where the clinical trial results start to feel personally real.

Side effects at 10mg can include a brief return of nausea or digestive changes for the first few days, following the now-familiar pattern. By this point in your treatment, you will likely have developed a reliable playbook for managing these - bland food on injection day, smaller portions, steady hydration - and the adjustment period tends to be shorter each time.

Some patients notice that constipation becomes more of a factor at higher doses, even if it was not an issue earlier. This is because tirzepatide's effect on gastric motility is dose-dependent, meaning the higher the dose, the more it slows digestion. Adequate water intake, fibre-rich foods, and daily movement are the first-line strategies, with over-the-counter options like Laxido available from your pharmacist if needed.

12.5mg and 15mg: The Higher Doses

These doses are typically reserved for patients who need additional weight loss beyond what the lower doses have achieved and who are tolerating the medication well. Not everyone reaches these levels, and reaching them is not a measure of success or failure - it is a clinical decision based on your individual response.

At 12.5mg and 15mg, appetite suppression is at its strongest, and patients at these doses often report eating significantly less than they did before treatment. This makes protein intake and overall nutritional quality even more important, because every meal needs to be nutritionally dense to compensate for the reduced volume of food.

The side-effect profile at these doses is generally consistent with what patients experienced at lower levels, though some find that digestive effects are slightly more persistent. Regular clinical reviews at these doses are important to ensure the medication continues to be appropriate and that weight loss is happening in a healthy, sustainable way.

The SURMOUNT-1 trial showed average weight loss of up to 22.5% at the highest Mounjaro dose over 72 weeks, which represents the strongest result of any injectable weight loss medication currently available.

What If a Dose Increase Is Too Difficult?

Sometimes a dose increase does not go smoothly. The nausea might be more intense than expected, or the digestive side effects might not settle within the usual timeframe. If that happens, you have options, and none of them involve pushing through in silence.

Your doctor can extend the time at your current dose before trying the increase again, which gives your body longer to adapt. In some cases, they may recommend stepping back to the previous dose temporarily if the higher one is causing significant problems. The titration schedule is a guide, not a rigid prescription, and your clinical team should be responsive to how you are actually feeling rather than following a calendar blindly.

At Bua, our clinical team is available through our secure messaging platform between scheduled reviews. If a dose increase is giving you trouble, reach out rather than waiting for your next appointment. That is exactly what ongoing clinical support is for.

Questions about your current dose or an upcoming increase? Bua patients can message their clinical team anytime through our secure platform.

The Bigger Picture

The dose escalation can feel like the whole story when you are in the middle of it, but it is really just the mechanism that gets you to the place where the medication works best for your body. Some patients arrive at that place at 5mg, others at 10mg, others at 15mg. The dose number matters far less than whether you are losing weight safely, feeling well, and building habits that will sustain your results long-term.

If you have not yet started treatment and want to understand whether Mounjaro could be right for you, you can check your eligibility online in under 4 minutes. Eligibility is determined by an IMC-registered doctor, and a prescription is not guaranteed.

Related Reading

• Am I eligible for Mounjaro in Ireland?
• Can my GP prescribe Mounjaro?
• Who can't take Mounjaro? Understanding the contraindications
• Wegovy vs Mounjaro in Ireland: which is right for you?
• Why medication alone isn't a silver bullet
• Mounjaro Side Effects in Ireland: What to Expect and How to Manage Them
• Your First Month on Mounjaro: What to Expect Week by Week

References

• Jastreboff, A. M., et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). NEJM. 2022;387(3):205-216.
• European Medicines Agency. Mounjaro: Summary of Product Characteristics.
• Eli Lilly and Company. Mounjaro KwikPen Patient Information Leaflet.

Related Blogs

Who Qualifies for Mounjaro in Ireland?

An overview of the clinical criteria, safety checks, and medical assessment process doctors use to decide who is eligible for Mounjaro® (tirzepatide) in Ireland.

Read

What weight loss injections are available in Ireland?

A clear breakdown of the three main medical treatments for weight management in Ireland in 2025 and 2026

Read

Who can't take Mounjaro? Understanding the contraindications

A comprehensive guide to the absolute contraindications and other cautions that determine who cannot safely take Mounjaro® (tirzepatide) in Ireland.

Read

Who Qualifies for Mounjaro in Ireland?

An overview of the clinical criteria, safety checks, and medical assessment process doctors use to decide who is eligible for Mounjaro® (tirzepatide) in Ireland.

Read

What weight loss injections are available in Ireland?

A clear breakdown of the three main medical treatments for weight management in Ireland in 2025 and 2026

Read

Who can't take Mounjaro? Understanding the contraindications

A comprehensive guide to the absolute contraindications and other cautions that determine who cannot safely take Mounjaro® (tirzepatide) in Ireland.

Read